Suppr超能文献

圣约翰草提取物 LI160 治疗有非典型特征的抑郁症 - 一项双盲、随机、安慰剂对照试验。

St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial.

机构信息

Department of Psychosomatic Medicine and Psychotherapy, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Germany.

出版信息

J Psychiatr Res. 2010 Sep;44(12):760-7. doi: 10.1016/j.jpsychires.2010.01.010. Epub 2010 Feb 23.

Abstract

Preliminary data suggest that hypericum extract LI160 is effective in atypical depression. Reported is the outcome of an 8-week double-blind, placebo-controlled, randomized trial of 600 mg LI160 vs. placebo in patients with vegetative features of atypical depression, i.e. hyperphagia or hypersomnia. One-hundred (100) patients with mild and 100 patients with moderate severity of a major depression according to ICD-10 were randomized. Patients needed to meet a score of 2 in at least one of the items 22-26 of the Hamilton-Depression-Rating-Scale (HAM-D) 28-item version and episode duration of at least 3 months. The primary outcome variable was the relative change of the HAM-D(17) from Baseline. Secondary outcome variables were the depression sub-score of the Patient Health Questionnaire (PHQ-9), the Clinical Global Impression (CGI), a patient's satisfaction scale, the Hamilton-Anxiety-Scale (HAM-A) and the sum score of atypical vegetative symptoms of the HAM-D(28). The percentage reduction of the HAM-D(17) for LI160 compared to placebo approached statistical significance (p=0.051) in the Full Analysis Set (FAS)-population. Using the conventional criterion of the absolute reduction of the HAM-D(17) significance was achieved (p<0.05). No significant benefit could be observed for the sum score of the atypical vegetative items of the HAM-D(28;) however, the sum score of the hypersomnia items (items 22-24) showed a significant superiority for LI160. The HAM-A, PHQ-9, and CGI-I scales demonstrated superiority of LI160 (p<0.01). Confining the analysis to moderately depressed patients, a highly significant benefit for the primary outcome variable was revealed. The study supports the beneficial effect of LI160 in depression with atypical features and the validity of the definition of atypical depression on the basis of reversed vegetative signs. Further, it identifies the PHQ-9 as a useful outcome variable in this population.

摘要

初步数据表明,贯叶金丝桃提取物 LI160 对非典型抑郁症有效。本文报道了一项为期 8 周的双盲、安慰剂对照、随机临床试验的结果,该试验比较了 LI160(600mg)与安慰剂在具有非典型抑郁植物性特征(即食欲过盛或嗜睡)的患者中的疗效。根据 ICD-10,轻度抑郁患者 100 例,中度抑郁患者 100 例。患者需要满足汉密尔顿抑郁评定量表(HAM-D)28 项版本的至少一项条目 22-26 评分为 2 分,且发作持续时间至少 3 个月。主要疗效变量是基线时 HAM-D(17)的相对变化。次要疗效变量包括患者健康问卷(PHQ-9)的抑郁子量表、临床总体印象(CGI)、患者满意度量表、汉密尔顿焦虑量表(HAM-A)和 HAM-D(28)的非典型植物性症状总分。LI160 与安慰剂相比,HAM-D(17)的百分比降低在全分析集(FAS)人群中接近统计学意义(p=0.051)。使用 HAM-D(17)绝对降低的传统标准,也达到了显著水平(p<0.05)。然而,HAM-D(28)的非典型植物性症状总分无显著改善,但是 HAM-D(22-24)的嗜睡项目总分显示 LI160 有显著优势。HAM-A、PHQ-9 和 CGI-I 量表显示 LI160 的优越性(p<0.01)。将分析仅限于中度抑郁患者,主要疗效变量显示出高度显著的获益。该研究支持 LI160 对具有非典型特征的抑郁症的有益作用,以及基于逆转的植物性症状的非典型抑郁症定义的有效性。此外,它确定 PHQ-9 是该人群中有用的疗效变量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验